Cefaclor
Cefaclor, sold under the trade name Ceclor among others, is a second-generation cephalosporin antibiotic used to treat certain bacterial infections such as pneumonia and infections of the ear, lung, skin, throat, and urinary tract. It is also available from other manufacturers as a generic.
Clinical data | |
---|---|
Trade names | Biocef, Ceclor, Medacef, Distaclor, Keflor, Raniclor |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682729 |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | Well absorbed, independent of food intake |
Metabolism | 15% to 40% |
Elimination half-life | 0.6 to 0.9 hours |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.053.536 |
Chemical and physical data | |
Formula | C15H14ClN3O4S |
Molar mass | 367.80 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
It was patented in 1973 and approved for medical use in 1979.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.